Latest Financials News

Clime Capital Limited signals a strong turnaround with a $7.8 million pretax profit for the half year ending December 2025, reversing last year's loss, and announces a higher franking rate for its upcoming dividend.

Hot Chili Limited has launched a A$40 million private placement to accelerate development of its Fuego copper project in Costa Rica, issuing shares at a discount to recent prices. The capital raise aims to boost exploration and feasibility studies while enhancing liquidity on the TSX Venture Exchange.

Pursuit Minerals Limited has had its trading suspension lifted following the release of its Pre-Feasibility Study and a capital raising announcement, signaling renewed investor interest.

Estrella Resources has entered a $2 million underwriting agreement to support the exercise of its listed options, ensuring capital inflow ahead of the December expiry.

Pursuit Minerals has delivered a compelling Pre-Feasibility Study for its Rio Grande Sur lithium project in Argentina, confirming strong economics and a maiden Ore Reserve. The company also secured a A$7 million capital raise to advance development.

Arcadia Minerals Limited has had its trading suspension lifted following a significant announcement about a proposed capital raising and an earn-in agreement on the Swanson Tantalum Mine.

Arcadia Minerals has secured a binding term sheet with Hongkong Xinhai Mining Services, granting Xinhai an exclusive option to advance the Swanson Tantalum Project in Namibia towards production through a strategic partnership and investment.

Hydrix Limited has amended its quarterly cash flow report, revealing stronger customer receipts and a stable cash position supported by robust financing facilities.

PYC Therapeutics has launched a A$653 million capital raising to fund the clinical advancement of four RNA-based drug candidates targeting genetic diseases with significant unmet needs. The raise extends the company’s cash runway to 2030, supporting key clinical milestones and a transition to commercialisation.

PYC Therapeutics has launched a substantial $653 million equity raise to fund clinical trials for four promising drug candidates targeting genetic diseases. This capital injection aims to advance the company’s pipeline through critical human efficacy milestones.

Cyclopharm has reported a record $32.3 million in operating revenue for FY2025, led by explosive growth in its U.S. Technegas market following FDA approval. The company reaffirms its ambitious target of 250–300 U.S. installations by mid-2026 amid strong clinical momentum.

Kairos Minerals has been granted a 21-year mining lease for its 1.4 million ounce Mt York Gold Project in Western Australia, marking a pivotal step towards advancing the project into production.